[go: up one dir, main page]

DK1265914T3 - WNT-1-relaterede polypeptider og nukleinsyrer, der koder for samme - Google Patents

WNT-1-relaterede polypeptider og nukleinsyrer, der koder for samme

Info

Publication number
DK1265914T3
DK1265914T3 DK01920759T DK01920759T DK1265914T3 DK 1265914 T3 DK1265914 T3 DK 1265914T3 DK 01920759 T DK01920759 T DK 01920759T DK 01920759 T DK01920759 T DK 01920759T DK 1265914 T3 DK1265914 T3 DK 1265914T3
Authority
DK
Denmark
Prior art keywords
wnt
same
nucleic acids
acids encoding
related polypeptides
Prior art date
Application number
DK01920759T
Other languages
English (en)
Inventor
Luca K Rastelli
Diane Pennica
Original Assignee
Curagen Corp
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curagen Corp, Genentech Inc filed Critical Curagen Corp
Application granted granted Critical
Publication of DK1265914T3 publication Critical patent/DK1265914T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/07Animals genetically altered by homologous recombination
    • A01K2217/075Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Seasonings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK01920759T 2000-03-22 2001-03-22 WNT-1-relaterede polypeptider og nukleinsyrer, der koder for samme DK1265914T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19125800P 2000-03-22 2000-03-22
PCT/US2001/009600 WO2001070775A2 (en) 2000-03-22 2001-03-22 Wnt-1 related polypeptides, and nucleic acids encoding the same

Publications (1)

Publication Number Publication Date
DK1265914T3 true DK1265914T3 (da) 2008-03-10

Family

ID=38885296

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01920759T DK1265914T3 (da) 2000-03-22 2001-03-22 WNT-1-relaterede polypeptider og nukleinsyrer, der koder for samme

Country Status (11)

Country Link
US (3) US20020098540A1 (da)
EP (1) EP1265914B1 (da)
JP (1) JP2003527849A (da)
AT (1) ATE382055T1 (da)
AU (2) AU2001247781C1 (da)
CA (1) CA2404216A1 (da)
DE (1) DE60132075T2 (da)
DK (1) DK1265914T3 (da)
ES (1) ES2298226T3 (da)
PT (1) PT1265914E (da)
WO (1) WO2001070775A2 (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0114644D0 (en) * 2001-06-15 2001-08-08 Oxford Glycosciences Uk Ltd Protein
EP1500665B1 (en) 2002-04-15 2011-06-15 Chugai Seiyaku Kabushiki Kaisha METHODS FOR CONSTRUCTING scDb LIBRARIES
ATE431423T1 (de) 2003-01-21 2009-05-15 Chugai Pharmaceutical Co Ltd Verfahren zum screening der leichten kette eines antikörpers
WO2004111233A1 (ja) 2003-06-11 2004-12-23 Chugai Seiyaku Kabushiki Kaisha 抗体の製造方法
EP1693386A4 (en) * 2003-11-04 2008-12-31 Chugai Pharmaceutical Co Ltd METHOD FOR THE PRODUCTION OF ANTIBODIES
US20050251054A1 (en) * 2004-05-10 2005-11-10 Medpond, Llc Method and apparatus for measurement of autonomic nervous system function
TWI671403B (zh) 2005-03-31 2019-09-11 中外製藥股份有限公司 控制組裝之多肽的製造方法
EP1870458B1 (en) 2005-03-31 2018-05-09 Chugai Seiyaku Kabushiki Kaisha sc(Fv)2 STRUCTURAL ISOMERS
CA2610987C (en) 2005-06-10 2013-09-10 Chugai Seiyaku Kabushiki Kaisha Stabilizer for protein preparation comprising meglumine and use thereof
KR101360671B1 (ko) 2005-06-10 2014-02-07 추가이 세이야쿠 가부시키가이샤 sc(Fv)2를 함유하는 의약조성물
DK2009101T3 (da) 2006-03-31 2018-01-15 Chugai Pharmaceutical Co Ltd Antistofmodifikationsfremgangsmåde til oprensning af et bispecifikt antistof
CA2730068A1 (en) 2008-07-07 2010-01-14 Oxford Nanopore Technologies Limited Base-detecting pore
EP2682460B1 (en) 2008-07-07 2017-04-26 Oxford Nanopore Technologies Limited Enzyme-pore constructs
GB0820927D0 (en) 2008-11-14 2008-12-24 Isis Innovation Method
CA2750879C (en) 2009-01-30 2018-05-22 Oxford Nanopore Technologies Limited Adaptors for nucleic acid constructs in transmembrane sequencing
CA2750874A1 (en) * 2009-01-30 2010-08-05 Oxford Nanopore Technologies Limited Hybridization linkers
GB0905140D0 (en) 2009-03-25 2009-05-06 Isis Innovation Method
AU2012215135B9 (en) 2011-02-11 2017-03-09 Oxford Nanopore Technologies Limited Mutant pores
KR20140050067A (ko) 2011-07-25 2014-04-28 옥스포드 나노포어 테크놀로지즈 리미티드 막횡단 포어를 사용한 이중 가닥 폴리뉴클레오티드 서열분석을 위한 헤어핀 루프 방법
US9777049B2 (en) 2012-04-10 2017-10-03 Oxford Nanopore Technologies Ltd. Mutant lysenin pores
US11155860B2 (en) 2012-07-19 2021-10-26 Oxford Nanopore Technologies Ltd. SSB method
GB201314695D0 (en) 2013-08-16 2013-10-02 Oxford Nanopore Tech Ltd Method
CN105209634B (zh) 2013-03-08 2020-05-12 牛津纳米孔技术公司 酶停滞方法
GB201313477D0 (en) 2013-07-29 2013-09-11 Univ Leuven Kath Nanopore biosensors for detection of proteins and nucleic acids
EP3050896B1 (en) 2013-09-27 2021-07-07 Chugai Seiyaku Kabushiki Kaisha Method for producing polypeptide heteromultimer
GB201403096D0 (en) 2014-02-21 2014-04-09 Oxford Nanopore Tech Ltd Sample preparation method
CN106459159B (zh) 2014-05-02 2021-11-30 牛津纳米孔技术公司 突变孔
JP7161291B2 (ja) 2014-09-01 2022-10-26 ブイアイビー ブイゼットダブリュ 変異体ポア
EP3204511B1 (en) 2014-10-07 2021-07-28 Oxford Nanopore Technologies Limited Mutant pores
GB201418159D0 (en) 2014-10-14 2014-11-26 Oxford Nanopore Tech Ltd Method
BR112018009312A8 (pt) 2015-12-28 2019-02-26 Chugai Pharmaceutical Co Ltd método para promover eficiência de purificação de polipeptídeo contendo região de fc
GB201609220D0 (en) 2016-05-25 2016-07-06 Oxford Nanopore Tech Ltd Method
GB201807793D0 (en) 2018-05-14 2018-06-27 Oxford Nanopore Tech Ltd Method
CN114457052B (zh) * 2021-09-17 2024-02-27 厦门大学 一种抗肿瘤的多肽组合物及其应用

Also Published As

Publication number Publication date
ES2298226T3 (es) 2008-05-16
DE60132075D1 (de) 2008-02-07
WO2001070775A3 (en) 2002-01-10
WO2001070775A2 (en) 2001-09-27
US20020098540A1 (en) 2002-07-25
AU2001247781B2 (en) 2006-02-02
US20080206252A1 (en) 2008-08-28
PT1265914E (pt) 2008-04-08
ATE382055T1 (de) 2008-01-15
DE60132075T2 (de) 2009-03-12
EP1265914B1 (en) 2007-12-26
JP2003527849A (ja) 2003-09-24
AU4778101A (en) 2001-10-03
CA2404216A1 (en) 2001-09-27
EP1265914A2 (en) 2002-12-18
US20050159373A1 (en) 2005-07-21
AU2001247781C1 (en) 2006-08-17

Similar Documents

Publication Publication Date Title
DK1265914T3 (da) WNT-1-relaterede polypeptider og nukleinsyrer, der koder for samme
NZ504548A (en) Polypeptides and nucleic acids encoding human chordin
ATE368053T1 (de) Antimikrobielle peptide
ES2137931T3 (es) Proteinas gdf-1 y uog-1.
DE60235039D1 (de) Egvii-endoglucanase und dafür codierende nukleinsäuren
DK1015586T3 (da) TIE-receptortyrosinkinaseligandhomologer
DK1490386T3 (da) Nyt polypeptid og nukleinsyrer kodende for dette
WO2002016418A3 (en) An iap binding peptide or polypeptide and methods of using the same
DE50112802D1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
BR9912455A (pt) ácidos nucléicos codificadores de proteìnas envolvidas em transdução sensória
ATE357526T1 (de) Modifizierte hcv peptid-impfstoffe
ATE453667T1 (de) Neovaskular-spezifische peptide
EA200100395A1 (ru) Фармацевтическая композиция, содержащая фрагменты днк, кодирующей антигенный белок, обладающая противоопухолевым действием
DE69940954D1 (de) Von mage-10 oder mage-8 abgeleitete hla-a2.1-bindende oligopeptide
EP1117682A4 (en) Novel peptides
DK0919621T3 (da) Human TAK1 og DNA der koder derfor
GB9416536D0 (en) Orphan receptor
WO2001070808A3 (en) Angiogenesis - associated proteins, and nucleic acids encoding the same
WO1999031229A3 (en) Peptides and nucleic acids derived from eisenia foetida and the use thereof
WO2001098355A3 (en) Cgi-69 compositions and methods of use
ATE315646T1 (de) Leukocyten-aktivierender faktor
ATE304553T1 (de) Polypeptide mit wasserkanalaktivität und dna sequenzen
DK0938555T3 (da) Konstruktioner og komplekser af cyclin E
CO5400145A1 (es) Proteina asociada con enfermedad
WO2002097036A3 (en) Compositions and methods for adipose abundant protein